共同药业 (300966.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

202.6x

Market Cap

CNY 2.80B

MomentumView details →

1D Return

−3.42%

YTD Return

+19.86%

RSI (14)

39.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

202.6x

Market Cap

CNY 2.80B

RSI (14)

39.2

MomentumView details →

1D Return

−3.42%

YTD Return

+19.86%

ProfitabilityView details →

Gross Margin

13.79%

Net Margin

−11.33%

EBITDA Margin

2.81%

ROE (TTM)

−8.59%

ROA (TTM)

−2.46%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

+13.61%

EPS YoY

—

FCF YoY

+89.83%

Revenue CAGR 3Y

+0.09%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.04x

Current Ratio

0.99x

Quick Ratio

0.41x

Div Yield

0.19%

Div Rate

CNY 0.05

Div Growth 1Y

+181.25%

Financials snapshotView financials →

Revenue (TTM)

628.90M

Net Income (TTM)

−71.24M

Op. CF (TTM)

69.91M

Latest newsMore news →

Shareholder Li Minglei reduced his stake in Gongtong Pharmaceutical by 2,197,200 shares, lowering his holding from 11.9059% to 10.0000%.61d ago

Similar companies

威力传动300904.SZ 中旗股份300575.SZ 三柏硕001300.SZ ST美晨300237.SZ *ST春兴002547.SZ 未来电器301386.SZ Find similar companies →

Latest newsMore news →

Shareholder Li Minglei reduced his stake in Gongtong Pharmaceutical by 2,197,200 shares, lowering his holding from 11.9059% to 10.0000%.61d ago